CVS Health (CVS) Tops Q1 EPS by 7c; Confirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
CVS Health (CVS) PT Raised to $88 at Evercore ISI; Model Bent Not Broken
May 2, 2017 12:27 PM EDTEvercore ISI raised its price target on CVS Health (NYSE: CVS) to $88.00 (from $87.00) while maintaining a Outperform rating following Q1 results.
Analyst Ross Muken believes shares are down today amid a "buyers strike" and bears who are feeling more emboldened. Meanwhile,... More
